HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.

Abstract
MEN 10710 is a new synthetic distamycin derivative possessing four pyrrole rings and a bis-(2-chloroethyl)aminophenyl moiety linked to the oligopyrrole backbone by a flexible butanamido chain. Its biological properties have been investigated in comparison with the structurally related compound, tallimustine (FCE24517), and the classical alkylating agent, melphalan (L-PAM). Cytotoxic potency of MEN 10710 was increased from 10- to 100-fold, as compared to tallimustine or L-PAM in murine L1210, human LoVo and MCF7 tumor cell lines. MEN 10710 was still active against L1210/L-PAM leukemic cells, while a partial cross-resistance was observed in LoVo/DX and in MCF7/DX cells selected for resistance to doxorubicin and expressing a MDR phenotype. Treatment with verapamil (VRP) reduced the resistance to tallimustine, but not to MEN 10710, in MCF7/DX cells. The cytotoxic effects reflect in vivo antitumor potency and toxicity in the treatment of human tumor xenografts. MEN 10710 was more effective in A2780/DDP, an ovarian carcinoma selected for resistance to cisplatin. On the other hand, the IC30 for inhibiting murine granulocyte/macrophage colony formation was 50 times higher for MEN 10710 than for tallimustine, suggesting a lower myelotoxic potential. In conclusion, the particular biological profile of MEN 10710 characterized by a marked cytotoxic potency, an interesting antitumor efficacy and a reduced in vitro myelosuppressive action may represent a further improvement in the rational design of a novel distamycin-related alkylating compound.
AuthorsM Bigioni, C Salvatore, C Palma, S Manzini, F Animati, P Lombardi, G Pratesi, R Supino, F Zunino
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 8 Issue 9 Pg. 845-52 (Oct 1997) ISSN: 0959-4973 [Print] England
PMID9402311 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Antineoplastic Agents, Alkylating
  • Calcium Channel Blockers
  • Distamycins
  • MEN 10710
  • Nitrogen Mustard Compounds
  • tallimustine
  • Verapamil
  • Melphalan
Topics
  • Animals
  • Antineoplastic Agents (pharmacokinetics, pharmacology)
  • Antineoplastic Agents, Alkylating (pharmacokinetics, pharmacology)
  • Calcium Channel Blockers (pharmacology)
  • Cell Survival
  • Distamycins (pharmacokinetics, pharmacology, therapeutic use)
  • Humans
  • Leukemia L1210 (drug therapy)
  • Melphalan (pharmacokinetics, pharmacology)
  • Mice
  • Neoplasm Transplantation
  • Neoplasms, Experimental (drug therapy)
  • Neoplastic Stem Cells
  • Nitrogen Mustard Compounds (pharmacokinetics, pharmacology, therapeutic use)
  • Organ Size (drug effects)
  • Tumor Cells, Cultured
  • Verapamil (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: